These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 27600618)

  • 21. Clinical significance of epithelial-mesenchymal transition-related markers expression in the micrometastatic sentinel lymph node of NSCLC.
    Lafuente-Sanchis A; Olmo A; Carretero J; Alcacer Fernandez-Coronado J; Estors-Guerrero M; Martínez-Hernández NJ; Cremades A; Zúñiga A; Alcacer J; Farras R; Cuenca M; Galbis-Caravajal JM
    Clin Transl Oncol; 2020 Mar; 22(3):381-391. PubMed ID: 31134511
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological significance of Sip1-associated epithelial mesenchymal transition in non-small cell lung cancer progression.
    Miura N; Yano T; Shoji F; Kawano D; Takenaka T; Ito K; Morodomi Y; Yoshino I; Maehara Y
    Anticancer Res; 2009 Oct; 29(10):4099-106. PubMed ID: 19846957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis.
    Na IK; Scheibenbogen C; Adam C; Stroux A; Ghadjar P; Thiel E; Keilholz U; Coupland SE
    Hum Pathol; 2008 Dec; 39(12):1751-5. PubMed ID: 18701133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Significance of the number of positive lymph nodes in resected non-small cell lung cancer.
    Fukui T; Mori S; Yokoi K; Mitsudomi T
    J Thorac Oncol; 2006 Feb; 1(2):120-5. PubMed ID: 17409840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
    Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
    Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of epithelial-mesenchymal transition driver brachyury and status of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in predicting treatment responses to neoadjuvant chemotherapy of breast cancer.
    Lee KH; Kim EY; Park YL; Do SI; Chae SW; Park CH
    Tumour Biol; 2017 Jun; 39(6):1010428317710575. PubMed ID: 28621227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive analysis of metastatic N1 lymph nodes in completely resected non-small-cell lung cancer.
    Park S; Cho S; Yum SW; Kim K; Jheon S
    Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):624-9. PubMed ID: 26242319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
    Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
    Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of aldehyde dehydrogenase 1 and transcription factors in both primary breast cancer and axillary lymph node metastases as a prognostic factor.
    Ito M; Shien T; Omori M; Mizoo T; Iwamoto T; Nogami T; Motoki T; Taira N; Doihara H; Miyoshi S
    Breast Cancer; 2016 May; 23(3):437-44. PubMed ID: 25599843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression and significance of Snail and Claudin-3 in non-small cell lung cancer].
    Li J; Tu Y; Jiang L; Xu H; Zhang S
    Zhongguo Fei Ai Za Zhi; 2012 Oct; 15(10):583-90. PubMed ID: 23075682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic implications of epithelial to mesenchymal transition related proteins (E-cadherin, Snail) and hypoxia inducible factor 1α in endometrioid endometrial carcinoma.
    Abouhashem NS; Ibrahim DA; Mohamed AM
    Ann Diagn Pathol; 2016 Jun; 22():1-11. PubMed ID: 27180053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer.
    Roselli M; Fernando RI; Guadagni F; Spila A; Alessandroni J; Palmirotta R; Costarelli L; Litzinger M; Hamilton D; Huang B; Tucker J; Tsang KY; Schlom J; Palena C
    Clin Cancer Res; 2012 Jul; 18(14):3868-79. PubMed ID: 22611028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung.
    Udagawa H; Ishii G; Morise M; Umemura S; Matsumoto S; Yoh K; Niho S; Ohmatsu H; Tsuboi M; Goto K; Ochiai A; Ohe Y
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1417-25. PubMed ID: 25573625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can a thoracic surgeon identify lymph node metastases during surgery based on their size? Analysis of 844 metastatic and 10,462 nonmetastatic lymph nodes.
    Suemitsu R; Takeo S; Matsuzawa H; Yamaguchi M; Momosaki S; Uesugi N
    J Thorac Oncol; 2010 Mar; 5(3):349-53. PubMed ID: 20009772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Micrometastatic P53-positive cells in the lymph nodes of non-small-cell lung cancer: prognostic significance.
    Dobashi K; Sugio K; Osaki T; Oka T; Yasumoto K
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):339-46. PubMed ID: 9305185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
    Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
    J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
    Higashi K; Ito K; Hiramatsu Y; Ishikawa T; Sakuma T; Matsunari I; Kuga G; Miura K; Higuchi T; Tonami H; Yamamoto I
    J Nucl Med; 2005 Feb; 46(2):267-73. PubMed ID: 15695786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
    Huang GJ; Fang DK; Cheng GY; Zhang DC
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BOK displays cell death-independent tumor suppressor activity in non-small-cell lung carcinoma.
    Moravcikova E; Krepela E; Donnenberg VS; Donnenberg AD; Benkova K; Rabachini T; Fernandez-Marrero Y; Bachmann D; Kaufmann T
    Int J Cancer; 2017 Nov; 141(10):2050-2061. PubMed ID: 28744854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.